<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Spermicide used alone for contraception - Grimes, DA - 2013 | Cochrane Library</title> <meta content="Spermicide used alone for contraception - Grimes, DA - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005218.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Spermicide used alone for contraception - Grimes, DA - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005218.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005218.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Spermicide used alone for contraception" name="citation_title"/> <meta content="David A Grimes" name="citation_author"/> <meta content="University of North Carolina, School of Medicine" name="citation_author_institution"/> <meta content="Laureen M Lopez" name="citation_author"/> <meta content="FHI 360" name="citation_author_institution"/> <meta content="Elizabeth G. Raymond" name="citation_author"/> <meta content="Gynuity Health projects" name="citation_author_institution"/> <meta content="Vera Halpern" name="citation_author"/> <meta content="FHI 360" name="citation_author_institution"/> <meta content="vhalpern@fhi360.org" name="citation_author_email"/> <meta content="Kavita Nanda" name="citation_author"/> <meta content="FHI 360" name="citation_author_institution"/> <meta content="Kenneth F Schulz" name="citation_author"/> <meta content="FHI 360 and UNC School of Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD005218.pub4" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/12/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005218.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005218.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005218.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Contraception [*methods]; Nonoxynol [*administration &amp; dosage]; Randomized Controlled Trials as Topic; Spermatocidal Agents [*administration &amp; dosage]; Vaginal Creams, Foams, and Jellies [administration &amp; dosage, chemistry]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005218.pub4&amp;doi=10.1002/14651858.CD005218.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005218\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005218\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005218.pub4",title:"Spermicide used alone for contraception",firstPublishedDate:"Dec 5, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Fertility Regulation Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005218.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005218.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005218.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005218.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005218.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005218.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005218.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005218.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005218.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005218.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1982 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005218.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/full#CD005218-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/full#CD005218-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/full#CD005218-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/full#CD005218-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/full#CD005218-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/full#CD005218-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/full#CD005218-sec1-0005"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/appendices#CD005218-sec1-0011"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005218.pub4/media/CDSR/CD005218/table_n/CD005218StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/media/CDSR/CD005218/table_n/CD005218StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Spermicide used alone for contraception</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information#CD005218-cr-0002">David A Grimes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information#CD005218-cr-0003">Laureen M Lopez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information#CD005218-cr-0004">Elizabeth G. Raymond</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information#CD005218-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>Vera Halpern</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information#CD005218-cr-0006">Kavita Nanda</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information#CD005218-cr-0007">Kenneth F Schulz</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information/en#CD005218-sec1-0015">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 December 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005218.pub4">https://doi.org/10.1002/14651858.CD005218.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005218-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005218-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005218-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005218-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005218-abs-0001" lang="en"> <section id="CD005218-abs1-0001"> <h3 class="title" id="CD005218-abs1-0001">Background</h3> <p>Spermicides have been used as contraceptives for thousands of years. Despite this long use, only recently have studies examined the comparative efficacy and acceptability of these vaginal medications. Spermicides contain an active ingredient (most commonly nonoxynol‐9) and a formulation used to disperse the product, such as foam or vaginal suppository. </p> </section> <section id="CD005218-abs1-0002"> <h3 class="title" id="CD005218-abs1-0002">Objectives</h3> <p>This review examined all known randomized controlled trials of a spermicide used alone for contraception. </p> </section> <section id="CD005218-abs1-0003"> <h3 class="title" id="CD005218-abs1-0003">Search methods</h3> <p>In August 2013, we searched the following computerized databases for randomized controlled trials of spermicides for contraception: CENTRAL, MEDLINE, POPLINE, LILACS, EMBASE, ClinicalTrials.gov, and ICTRP. For the initial review, we examined the reference lists of trials found as well as those of review articles and textbook chapters. </p> </section> <section id="CD005218-abs1-0004"> <h3 class="title" id="CD005218-abs1-0004">Selection criteria</h3> <p>We included any trial of a commercial product used alone for contraception. Each included trial must have provided sufficient information to determine pregnancy rates. </p> </section> <section id="CD005218-abs1-0005"> <h3 class="title" id="CD005218-abs1-0005">Data collection and analysis</h3> <p>Two authors independently extracted information from the trials identified. We did not conduct a meta‐analysis, since most trials had large losses to follow up. We entered the data into tables and presented the results descriptively. </p> </section> <section id="CD005218-abs1-0006"> <h3 class="title" id="CD005218-abs1-0006">Main results</h3> <p>We located reports from 14 trials for the initial review, but have not identified any new trials since then. In the largest trial to date, the gel (Advantage S) containing the lowest dose of nonoxynol‐9 (52.5 mg) was significantly less effective in preventing pregnancy than were gels with higher doses of the same agent (100 mg and 150 mg). Probabilities of pregnancy by six months were 22% for the 52.5 mg gel, 16% for the 100 mg dose, and 14% for the 150 mg dose. In the same trial, the three different vehicles with 100 mg of nonoxynol‐9 had similar efficacy. Interpretation of these figures is limited, since 39% of participants discontinued the method or were lost from the trial. Few important differences in efficacy emerged in other trials. </p> </section> <section id="CD005218-abs1-0007"> <h3 class="title" id="CD005218-abs1-0007">Authors' conclusions</h3> <p>The probability of pregnancy varied widely in reported trials. A gel containing nonoxynol‐9 52.5 mg was inferior to two other products tested in the largest trial. Aside from this finding, personal characteristics and behavior of users may be more important than characteristics of the spermicide products in determining the probability of pregnancy. Gel was liked more than the film or vaginal suppository in the largest trial. Spermicide trials have the dual challenges of difficult recruitment and high discontinuation rates; the latter threatens trial validity. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005218-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005218-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005218-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005218-abs-0005">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005218-abs-0004" lang="en"> <h3>Spermicide used alone for birth control</h3> <p>Spermicides have been used as birth control for thousands of years. Studies have recently looked at how well they work to prevent pregnancy and whether women like them. Spermicides contain an active ingredient (usually nonoxynol‐9) and something to disperse the product, such as foam or vaginal suppository (pessary). This review compared how well different spermicides worked for birth control when used alone. </p> <p>In August 2013, we did computer searches for randomized trials of spermicides used for birth control. We have not found any new trials since the initial review. For the initial review, we also wrote to researchers to find other trials. </p> <p>Trials had to focus on a spermicide used alone for birth control. The product could be compared to a different spermicide, the same spermicide used with a barrier method, another dose of the same spermicide, a different base for the same product, or another type of birth control. Each study must have had data on pregnancy. </p> <p>We located reports from 14 trials for the initial review. We have not found any new trials since then. The largest trial compared five different spermicides. The gel with the smallest amount of nonoxynol‐9 did not prevent pregnancy as well as products with more of the same ingredient. Women liked the gel better than the film or suppository. Few differences were found in the other studies. These trials had problems recruiting women into the studies and then keeping them until the trial ended. Large losses to follow up can bias the results. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005218-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005218-sec1-0006"></div> <h3 class="title" id="CD005218-sec1-0007">Implications for practice</h3> <section id="CD005218-sec1-0007"> <p>Most trials to date were so poorly done that drawing conclusions about the comparative efficacy of spermicides is not possible. The pregnancy probabilities varied widely in reported trials, but have been as high as 28% over six months of use (<a href="./references#CD005218-bbs2-0010" title="RaymondE , DominikR , the spermicide trial group. Contraceptive effectiveness of two spermicides: a randomized trial. Obstetrics and Gynecology1999;93(6):896‐903. RaymondEG , AlvaradoG , LedesmaL , DiazS , BassolS , MoralesE , et al. Acceptability of two spermicides in five countries. Contraception1999;60(1):45‐50. ">Raymond 1999</a>). Few important differences emerged between products, although a gel containing nonoxynol‐9 52.5 mg was inferior to two other products tested in one trial (<a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>). Aside from this one product, personal characteristics and behavior of users may be more important than characteristics of the spermicide products themselves in determining the likelihood of pregnancy. Gel may be a more acceptable spermicide formulation than film or vaginal suppository (<a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>). In general use outside of research settings, spermicides fall into the bottom tier of contraceptive effectiveness (<a href="./references#CD005218-bbs2-0029" title="SteinerMJ , DaleboutS , CondonS , DominikR , TrussellJ . Understanding risk: a randomized controlled trial of communicating contraceptive effectiveness. Obstetrics and Gynecology2003;102(4):709‐17. ">Steiner 2003</a>). On the other hand, advantages of spermicides for women at low risk of HIV infection include easy availability, moderate cost, absence of systemic effects, and control by the woman. </p> </section> <h3 class="title" id="CD005218-sec1-0008">Implications for research</h3> <section id="CD005218-sec1-0008"> <p>Randomized controlled trials of spermicides pose daunting challenges for investigators. Because of the limited appeal and effectiveness of spermicides, recruitment to recent trials has been difficult. In addition, many women discontinued their assigned method before the end of the trial (<a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>). Women who discontinue their assigned method should be followed until the end of the trial; this often did not happen in published trials. In several studies, losses to follow up after randomization were high as well. As a result, many reports are difficult to interpret. Future trials need to address the dual challenges of recruitment and retention of participants. Shorter observation periods may enhance compliance with the assigned treatments. Innovative approaches may be needed to achieve high rates of follow up (<a href="./references#CD005218-bbs2-0024" title="RoddyRE , ZekengL , RyanKA , TamoufeU , TweedyKG . Effect of nonoxynol‐9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial. Journal of the American Medical Association2002;287(9):1117‐22. ">Roddy 2002</a>; <a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>). </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005218-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005218-sec1-0001"></div> <p>Although vaginal spermicides have been used as contraceptives for millennia, only recently have these methods received scientific scrutiny. Spermicides are designed to prevent fertilization by killing or inactivating sperm as they ascend through the female genital tract. All spermicide products have two components: a chemical toxic to sperm and a formulation (also called a carrier or base) for its delivery (<a href="./references#CD005218-bbs2-0020" title="CatesWJr , HarwoodB . Vaginal barriers and spermicides. In: HatcherRA , TrussellJ , NelsonAL , CatesWJr , KowalD , PolicarMS , et al. editor(s). Contraceptive Technology. 20th Edition. New York: Ardent Media, Inc., 2011:391‐408. ">Cates 2011</a>). The chemicals used in currently available spermicides are usually surfactants, the most common being nonoxynol‐9. 'Nonoxinol' is also a recognized spelling for this chemical. Other agents include octoxynol, menfegol, and benzalkonium chloride (<a href="./references#CD005218-bbs2-0021" title="ConnellEB . The contraception sourcebook. Chicago: Contemporary Books, 2002. ">Connell 2002</a>; <a href="./references#CD005218-bbs2-0028" title="SperoffL , DarneyPD . A Clinical Guide for Contraception. 3rd Edition. Philadephia, PA: Williams &amp; Wilkins, 2001. ">Speroff 2001</a>). These agents dissolve the lipid components in the cell membrane of spermatozoa, resulting in their death or inactivation. Nonoxynol‐9 spermicides contain 52.5 to 230 mg (<a href="./references#CD005218-bbs2-0022" title="Embil PharmaceuticalCompany . Spermicidal. www.embil.com/spermicidal.html (accessed 4 March 2005). ">Embil 2005</a>) of the active agent per application. The vehicles used to deliver the spermicide include foam, jelly, cream, melting suppository, foaming suppository, foaming tablet, and soluble film (<a href="./references#CD005218-bbs2-0027" title="SherrisJD , MooreSH , FoxG . New developments in vaginal contraception. Population Reports1984;XII:H‐157‐91. ">Sherris 1984</a>). A vaginal suppository may also be called a pessary. Unlike the melting suppository, the foaming suppository uses a chemical base that, when moistened, releases carbon dioxide bubbles to help distribute the spermicide. Instructions for use vary by product; tablets, suppositories, and film need time to melt to allow dispersal of the spermicide in the vagina. Users are advised to insert spermicides from 0 to 30 minutes before coitus. While some jellies, creams, and foams may protect for as long as eight hours, tablets and suppositories may be effective for only one hour (<a href="./references#CD005218-bbs2-0028" title="SperoffL , DarneyPD . A Clinical Guide for Contraception. 3rd Edition. Philadephia, PA: Williams &amp; Wilkins, 2001. ">Speroff 2001</a>). The scientific basis for these statements about duration of contraceptive activity is elusive. </p> <p>Current spermicides have important advantages and disadvantages. These products are widely available 'over‐the‐counter' and generally cost less than hormonal contraceptives. No systemic absorption occurs (<a href="./references#CD005218-bbs2-0027" title="SherrisJD , MooreSH , FoxG . New developments in vaginal contraception. Population Reports1984;XII:H‐157‐91. ">Sherris 1984</a>). These products are simple to use and are under the control of the woman. Some women report that the lubrication provided by spermicide improved intercourse for them (<a href="./references#CD005218-bbs2-0033" title="VandeboschA , GoetghebeurE , RamjeeG , AlaryM , Ettiegne‐TraoreV , ChandeyingV , et al. Acceptability of COL‐1492, a vaginal gel, among sex workers in one Asian and three African cities. Sexually Transmitted Infections2004;80(3):241‐3. ">Vandebosch 2004</a>). Although protection against some sexually‐transmitted infections had been reported in the past, primarily with in vitro studies, more recent clinical trials have not confirmed this benefit (<a href="./references#CD005218-bbs2-0020" title="CatesWJr , HarwoodB . Vaginal barriers and spermicides. In: HatcherRA , TrussellJ , NelsonAL , CatesWJr , KowalD , PolicarMS , et al. editor(s). Contraceptive Technology. 20th Edition. New York: Ardent Media, Inc., 2011:391‐408. ">Cates 2011</a>; <a href="./references#CD005218-bbs2-0023" title="RoddyR , ZekengL , RyanKA , TamoufeU , WeirSS , WongEL . A controlled trial of nonoxynol 9 film to reduce male‐to‐female transmission of sexually transmitted diseases. New England Journal of Medicine1998;339(8):504‐10. ">Roddy 1998</a>; <a href="./references#CD005218-bbs2-0024" title="RoddyRE , ZekengL , RyanKA , TamoufeU , TweedyKG . Effect of nonoxynol‐9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial. Journal of the American Medical Association2002;287(9):1117‐22. ">Roddy 2002</a>; <a href="./references#CD005218-bbs2-0032" title="VanDammeL , RamjeeG , AlaryM , VuylstekeB , ChandeyingV , ReesH , et al. Effectiveness of COL‐1492, a nonoxynol‐9 vaginal gel, on HIV‐1 transmission in female sex workers: a randomised controlled trial. Lancet2002;360(9338):971‐7. ">Van Damme 2002</a>). Spermicides with nonoxynol‐9 are not effective as microbicides, and may increase susceptibility to HIV if used more than twice a day (<a href="./references#CD005218-bbs2-0020" title="CatesWJr , HarwoodB . Vaginal barriers and spermicides. In: HatcherRA , TrussellJ , NelsonAL , CatesWJr , KowalD , PolicarMS , et al. editor(s). Contraceptive Technology. 20th Edition. New York: Ardent Media, Inc., 2011:391‐408. ">Cates 2011</a>). </p> <p>A central challenge for all spermicides is maintaining the balance between contraceptive protection and disturbing the vaginal environment (<a href="./references#CD005218-bbs2-0036" title="ZaneveldLJD , AndersonDJ , WhaleyKJ . Part 1. Barrier methods. In: HarrisonP , RosenfieldA editor(s). Contraceptive research and development. Looking to the future. Washington, D.C.: National Academy Press, 1996:430‐45. ">Zaneveld 1996</a>). Spermicides act as cytotoxins and can injure vaginal and cervical epithelium. Frequent use may alter the vaginal flora, possibly leading to an increased risk of urinary tract infection (<a href="./references#CD005218-bbs2-0025" title="ScholesD , HootenTM , RobertsPL , StapletonAE , GuptaK , StammWE . Risk factors for recurrent urinary tract infection in young women. Journal of Infectious Diseases2000;182(4):1177‐82. ">Scholes 2000</a>). It can also damage the epithelium, possibly facilitating infection with HIV among female sex workers (<a href="./references#CD005218-bbs2-0034" title="World Health Organization. WHO/CONRAD technical consultation on nonoxynol‐9, World Health Organization, Geneva, 9‐10 October 2001: summary report. Reproductive Health Matters2002;10(20):175‐81. ">WHO 2002</a>). The World Health Organization considers spermicides a category 4 method (contraindicated) for women at high risk of HIV infection and category 3 for those already infected (<a href="./references#CD005218-bbs2-0035" title="World Health Organization. Medical eligibility criteria for contraceptive use. Fourth edition. http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdf. 3 (accessed 05 Aug 2013). ">WHO 2010</a>). The probability of pregnancy with spermicide alone varies widely. In the first year of use, unintended pregnancies occur in 18% of women with perfect use and 28% of those with typical use (<a href="./references#CD005218-bbs2-0031" title="TrussellJ . Contraceptive failure in the United States. Contraception2011;83(5):397‐404. ">Trussell 2011</a>). Allergy or sensitivity to the spermicide has been reported in 1% to 5% of users. Other users note irritation of genital tissues or a sensation of heat. Some couples find this method messy (<a href="./references#CD005218-bbs2-0036" title="ZaneveldLJD , AndersonDJ , WhaleyKJ . Part 1. Barrier methods. In: HarrisonP , RosenfieldA editor(s). Contraceptive research and development. Looking to the future. Washington, D.C.: National Academy Press, 1996:430‐45. ">Zaneveld 1996</a>). </p> <p>This review examined spermicides used alone for contraception, although spermicides are commonly used with barrier contraceptives, such as the condom, diaphragm, sponge, and cervical cap. </p> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005218-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005218-sec1-0002"></div> <p>To compare the probability of pregnancy among women using a spermicide alone versus any other contraceptive, including another spermicide. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005218-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005218-sec1-0003"></div> <section id="CD005218-sec2-0001"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005218-sec3-0001"> <h4 class="title">Types of studies</h4> <p>We included all randomized controlled trials in any language that compared any spermicide used alone for contraception with another method; pregnancy must have been reported as an outcome. The comparison method could have been a different spermicide, the same spermicide used with a barrier method, a different dose of the same spermicide, a different formulation for the same spermicide, or another type of contraceptive altogether. </p> </section> <section id="CD005218-sec3-0002"> <h4 class="title">Types of participants</h4> <p>All women included in the eligible trials were incorporated in this review.</p> </section> <section id="CD005218-sec3-0003"> <h4 class="title">Types of interventions</h4> <p>We included any commercially‐available spermicide used for prevention of pregnancy. Trials using spermicides for prevention of sexually‐transmitted infections were excluded. Any active agent was considered. No natural substances, such as lime juice, were included, because evaluations have not been completed. Formulations included foam, jelly, cream, suppository or pessary, tablet, and film. Most reports did not provide specific information about the composition of the vehicles in the products tested. At least one treatment arm in each included trial must have used spermicide alone for contraception. </p> </section> <section id="CD005218-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <section id="CD005218-sec4-0001"> <h5 class="title">Primary outcomes</h5> <p>Each trial must have had reported pregnancies as an outcome.</p> </section> <section id="CD005218-sec4-0002"> <h5 class="title">Secondary outcomes</h5> <p>These measures included continuation rates, side effects, and acceptability. Changes to vaginal epithelium were included if reported. Reporting of side effects reflected definitions of outcomes used by investigators. </p> <p>We excluded trials that only reported surrogate endpoints, such as in vitro effects on sperm motility. </p> </section> </section> </section> <section id="CD005218-sec2-0002"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005218-sec3-0005"> <h4 class="title">Electronic searches</h4> <p>In August 2013, we searched computerized databases for randomized controlled trials of spermicides for contraception: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, POPLINE, and LILACS. We also searched for trials via ClinicalTrials.gov and the search portal of the International Clinical Trials Registry Platform (ICTRP). Search strategies are shown in <a href="./appendices#CD005218-sec2-0007">Appendix 1</a>. Previous strategies can be found in <a href="./appendices#CD005218-sec2-0008">Appendix 2</a>. We did not use 'infection' in the search strategy, because microbicides were not the focus of this review. </p> </section> <section id="CD005218-sec3-0006"> <h4 class="title">Searching other resources</h4> <p>For the initial review, we examined the reference lists of trials found as well as those of review articles and textbook chapters. We wrote to the author of each published trial identified to solicit other published or unpublished trials that we may have missed. Discussions with an investigator revealed unpublished trial reports, which we then included. </p> </section> </section> <section id="CD005218-sec2-0003"> <h3 class="title" id="CD005218-sec2-0003">Data collection and analysis</h3> <p>We assessed for inclusion all titles and abstracts that we found. We evaluated the methodological quality of the trials for potential biases by qualitatively assessing the study design, randomization method, allocation concealment, blinding, and rates for premature discontinuation and loss to follow up. One potentially relevant trial was published in Chinese (<a href="./references#CD005218-bbs2-0018" title="XuJX , ShiLT , ZhouXB , XiaoZQ . Contraceptive efficacy of bioadhesive nonoxynol‐9 gel: comparison with nonoxynol‐9 suppository. Chinese Journal of Obstetrics and Gynecology2003;38(10):629‐31. ">Xu 2003</a>); we had this article translated into English. Correspondence with the author later revealed that it was not a randomized trial. </p> <p>Two authors independently abstracted data from the studies identified to improve accuracy. Most studies had problems with recruitment and large losses to follow up. Therefore, we did not conduct a meta‐analysis. Most studies reported the 6‐month or 12‐month life‐table rates per 100 women or the probabilities. We entered those data into tables in RevMan. The results are presented descriptively. Information on statistical significance came from the individual trial reports. </p> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005218-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005218-sec1-0004"></div> <section id="CD005218-sec2-0004"> <h3 class="title">Description of studies</h3> <section id="CD005218-sec3-0007"> <h4 class="title">Results of the search</h4> <p>The 2013 search produced 20 unduplicated references. These included 17 citations from the main databases plus 1 from another source. We also identified two items from the searches of ClinicalTrials.gov and ICTRP but none were eligible. </p> </section> <section id="CD005218-sec3-0008"> <h4 class="title">Included studies</h4> <p>The spermicides tested in these studies are listed in <a href="#CD005218-tbl-0008">Table 1</a>. </p> <div class="table" id="CD005218-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of spermicides tested</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand name</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Spermicide and dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neo Sampoon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Menfegol 60 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0001" title="Family Health International for Abdelsalaam A. A comparative study of Neo Sampoon tablets versus Emko tablets in Zagazig, Egypt. Unpublished report, Family Health International, May 1984. ">Abdelsalaam 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0002" title="Family Health International for Andolsek L. A comparative clinical trial of Neo Sampoon vaginal tablets and Emko vaginal foam in Ljubljana, Yugoslavia. Unpublished report, Family Health International, April 1988. ">Andolsek 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0003" title="ChiI‐c , SmithSC , BorkoE , SunT‐H , BegumSF , HuntWL , et al. Clinical acceptability, use patterns and use‐effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets ‐ an international multi‐center randomized clinical trial. Contraception1987;36(36):499‐514. ">Chi 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0006" title="Family Health International for Kazi A. A comparative study of two foaming vaginal tablets for female barrier contraception in Pakistan. Unpublished report, Family Health International, September 1992. ">Kazi 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0014" title="YoussefH , CroftonVA , SmithSC , SiemensAJ . A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt. Contraception1987;35(2):101‐10. ">Youssef 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho menfegol foaming tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Menfegol 60 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0004" title="ChompootaweepS , DusitinN . A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol‐9 versus menfegol) in Thai women. Contraception1990;41(5):507‐17. ">Chompootaweep 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0005" title="Family Health International for Ghunney E. Evaluation of the safety, effectiveness and acceptability of Ortho foaming vaginal tablets containing nonoxynol‐9 versus Ortho foaming tablets containing menfegol at a clinic in Accra, Ghana. Unpublished report, Family Health International, December 1987. ">Ghunney 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0007" title="Family Health International for Klufio C. Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming tablets containing menfegol at a hospital in Accra, Ghana. Unpublished report, Family Health International, February 1988. ">Klufio 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0012" title="Family Health International for Ruoff G, NilandN , HalkiJ . Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming vaginal tablets containing menfegol at three U.S. sites. Unpublished report, Family Health International, February 1988. ">Ruoff 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Collatex sponge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 1.15 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0003" title="ChiI‐c , SmithSC , BorkoE , SunT‐H , BegumSF , HuntWL , et al. Clinical acceptability, use patterns and use‐effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets ‐ an international multi‐center randomized clinical trial. Contraception1987;36(36):499‐514. ">Chi 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emko tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0001" title="Family Health International for Abdelsalaam A. A comparative study of Neo Sampoon tablets versus Emko tablets in Zagazig, Egypt. Unpublished report, Family Health International, May 1984. ">Abdelsalaam 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0002" title="Family Health International for Andolsek L. A comparative clinical trial of Neo Sampoon vaginal tablets and Emko vaginal foam in Ljubljana, Yugoslavia. Unpublished report, Family Health International, April 1988. ">Andolsek 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0009" title="Family Health International for Poindexter A III. A comparative study of Emko and Ortho vaginal tablets in Houston, Texas. Unpublished report, Family Health International, August 1984. ">Poindexter 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0013" title="Family Health International for Younis N. A comparative clinical trial of Emko and Ortho vaginal tablets in Cairo, Egypt. Unpublished report, Family Health International, October 1985. ">Younis 1985</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emko foam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0002" title="Family Health International for Andolsek L. A comparative clinical trial of Neo Sampoon vaginal tablets and Emko vaginal foam in Ljubljana, Yugoslavia. Unpublished report, Family Health International, April 1988. ">Andolsek 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0014" title="YoussefH , CroftonVA , SmithSC , SiemensAJ . A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt. Contraception1987;35(2):101‐10. ">Youssef 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho foaming tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0004" title="ChompootaweepS , DusitinN . A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol‐9 versus menfegol) in Thai women. Contraception1990;41(5):507‐17. ">Chompootaweep 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0005" title="Family Health International for Ghunney E. Evaluation of the safety, effectiveness and acceptability of Ortho foaming vaginal tablets containing nonoxynol‐9 versus Ortho foaming tablets containing menfegol at a clinic in Accra, Ghana. Unpublished report, Family Health International, December 1987. ">Ghunney 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0007" title="Family Health International for Klufio C. Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming tablets containing menfegol at a hospital in Accra, Ghana. Unpublished report, Family Health International, February 1988. ">Klufio 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0012" title="Family Health International for Ruoff G, NilandN , HalkiJ . Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming vaginal tablets containing menfegol at three U.S. sites. Unpublished report, Family Health International, February 1988. ">Ruoff 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0006" title="Family Health International for Kazi A. A comparative study of two foaming vaginal tablets for female barrier contraception in Pakistan. Unpublished report, Family Health International, September 1992. ">Kazi 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0009" title="Family Health International for Poindexter A III. A comparative study of Emko and Ortho vaginal tablets in Houston, Texas. Unpublished report, Family Health International, August 1984. ">Poindexter 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0013" title="Family Health International for Younis N. A comparative clinical trial of Emko and Ortho vaginal tablets in Cairo, Egypt. Unpublished report, Family Health International, October 1985. ">Younis 1985</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0010" title="RaymondE , DominikR , the spermicide trial group. Contraceptive effectiveness of two spermicides: a randomized trial. Obstetrics and Gynecology1999;93(6):896‐903. RaymondEG , AlvaradoG , LedesmaL , DiazS , BassolS , MoralesE , et al. Acceptability of two spermicides in five countries. Contraception1999;60(1):45‐50. ">Raymond 1999</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VCF film</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 72 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0010" title="RaymondE , DominikR , the spermicide trial group. Contraceptive effectiveness of two spermicides: a randomized trial. Obstetrics and Gynecology1999;93(6):896‐903. RaymondEG , AlvaradoG , LedesmaL , DiazS , BassolS , MoralesE , et al. Acceptability of two spermicides in five countries. Contraception1999;60(1):45‐50. ">Raymond 1999</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advantage S gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 52.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 150 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol film</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Encare suppository</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> </p> </td> </tr> </tbody> </table> </div> <p><a href="./references#CD005218-bbs2-0001" title="Family Health International for Abdelsalaam A. A comparative study of Neo Sampoon tablets versus Emko tablets in Zagazig, Egypt. Unpublished report, Family Health International, May 1984. ">Abdelsalaam 1984</a> compared the Neo Sampoon foaming tablet (menfegol 60 mg) and the Emko vaginal tablet (nonoxynol‐9 100 mg) among 200 women at a university hospital in Egypt. The duration of the trial was 12 months. </p> <p><a href="./references#CD005218-bbs2-0002" title="Family Health International for Andolsek L. A comparative clinical trial of Neo Sampoon vaginal tablets and Emko vaginal foam in Ljubljana, Yugoslavia. Unpublished report, Family Health International, April 1988. ">Andolsek 1988</a> conducted a similar trial comparing the Neo Sampoon tablets versus Emko vaginal foam among 271 women in Ljubljana (former Yugoslavia). The trial took place at a university medical center and followed women for 12 months. </p> <p><a href="./references#CD005218-bbs2-0003" title="ChiI‐c , SmithSC , BorkoE , SunT‐H , BegumSF , HuntWL , et al. Clinical acceptability, use patterns and use‐effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets ‐ an international multi‐center randomized clinical trial. Contraception1987;36(36):499‐514. ">Chi 1987</a> compared the Collatex vaginal sponge (the predecessor of the Today vaginal sponge) with the Neo Sampoon foaming tablet. The Collatex sponge contained 1.15 g of nonoxynol‐9 and was designed to provide 48 hours of protection. The Neo Sampoon foaming tablet contains menfegol 60 mg. A total of 1299 women participated at the four sites, which were Belgrade and Maribor (former Yugoslavia), Taiwan and Bangladesh. Follow up lasted 12 months. </p> <p><a href="./references#CD005218-bbs2-0004" title="ChompootaweepS , DusitinN . A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol‐9 versus menfegol) in Thai women. Contraception1990;41(5):507‐17. ">Chompootaweep 1990</a> compared foaming vaginal tablets containing either nonoxynol‐9 (100 mg) or menfegol (60 mg). A total of 102 participants were recruited at three different sites: a factory clinic, a university clinic, and a health center. Observation continued for 12 months. </p> <p><a href="./references#CD005218-bbs2-0005" title="Family Health International for Ghunney E. Evaluation of the safety, effectiveness and acceptability of Ortho foaming vaginal tablets containing nonoxynol‐9 versus Ortho foaming tablets containing menfegol at a clinic in Accra, Ghana. Unpublished report, Family Health International, December 1987. ">Ghunney 1987</a> compared two Ortho vaginal tablets in a clinic in Ghana. One contained nonoxynol‐9 100 mg, and the other contained menfegol 60 mg. Only 27 of the planned 150 women were enrolled, and the study was closed prematurely due to recruitment difficulties. </p> <p><a href="./references#CD005218-bbs2-0006" title="Family Health International for Kazi A. A comparative study of two foaming vaginal tablets for female barrier contraception in Pakistan. Unpublished report, Family Health International, September 1992. ">Kazi 1992</a> compared the Neo Sampoon tablet versus the Ortho Conceptrol tablet containing nonoxynol‐9 100 mg. The trial took place at nine sites in Pakistan and enrolled 172 women for 12 months of observation. </p> <p>Based at a teaching hospital in Ghana, <a href="./references#CD005218-bbs2-0007" title="Family Health International for Klufio C. Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming tablets containing menfegol at a hospital in Accra, Ghana. Unpublished report, Family Health International, February 1988. ">Klufio 1988</a> compared the Ortho vaginal tablets containing either nonoxynol‐9 100 mg or menfegol 60 mg in 150 women. </p> <p><a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> compared the Neo Sampoon vaginal tablet (containing menfegol 60 mg) with two different brands of vaginal tablets (each containing nonoxynol‐9 100 mg). The trial included two sites in Ghana; one was a teaching hospital and the other was a polyclinic. Three hundred women were recruited; the observation period lasted 12 months. </p> <p>In Texas, <a href="./references#CD005218-bbs2-0009" title="Family Health International for Poindexter A III. A comparative study of Emko and Ortho vaginal tablets in Houston, Texas. Unpublished report, Family Health International, August 1984. ">Poindexter 1984</a> randomized 110 women to either the Ortho vaginal tablet (nonoxynol‐9 100 mg) or the Emko vaginal tablet (nonoxynol‐9 100 mg). Recruitment took place at a university medical center and three family planning clinics. Follow up was 12 months. </p> <p>A multicenter trial evaluated whether the vaginal contraceptive film should be distributed in commodities programs of the U.S. Agency for International Development (<a href="./references#CD005218-bbs2-0010" title="RaymondE , DominikR , the spermicide trial group. Contraceptive effectiveness of two spermicides: a randomized trial. Obstetrics and Gynecology1999;93(6):896‐903. RaymondEG , AlvaradoG , LedesmaL , DiazS , BassolS , MoralesE , et al. Acceptability of two spermicides in five countries. Contraception1999;60(1):45‐50. ">Raymond 1999</a>). The spermicidal tablet was already being distributed, and evaluation was requested to inform a decision about whether to include the film. The VCF vaginal contraceptive film contains nonoxynol‐9 72 mg; the comparison was a foaming vaginal tablet containing 100 mg of the same active agent. The trial was conducted at eight sites in Mexico, Ecuador, Guatemala, Ghana, and the U.S. A total of 765 women were enrolled; observation lasted 28 weeks. </p> <p>Another trial at 14 sites in the U.S. evaluated different doses of, and vehicles for, nonoxynol‐9 (<a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>). By using five different treatments, the investigators were able to compare three different doses of nonoxynol‐9 (52.5 mg, 100 mg, and 150 mg) in gels and three different formulations (gel, film, and suppository) with the same dose of spermicide (100 mg). A total of 1536 women were enrolled; the observation period lasted 30 weeks. </p> <p><a href="./references#CD005218-bbs2-0012" title="Family Health International for Ruoff G, NilandN , HalkiJ . Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming vaginal tablets containing menfegol at three U.S. sites. Unpublished report, Family Health International, February 1988. ">Ruoff 1988</a> compared the Ortho foaming tablet containing either nonoxynol‐9 100 mg or menfegol 60 mg. The trial took place at clinics in three different U.S. states. Only 60 of the planned 150 participants were enrolled, and the trial was stopped prematurely because of recruitment difficulties. </p> <p>At a university hospital in Egypt, <a href="./references#CD005218-bbs2-0013" title="Family Health International for Younis N. A comparative clinical trial of Emko and Ortho vaginal tablets in Cairo, Egypt. Unpublished report, Family Health International, October 1985. ">Younis 1985</a> randomized 140 women to either the Ortho or Emko vaginal tablets (each containing nonoxynol‐9 100 mg) and followed them for 12 months. </p> <p><a href="./references#CD005218-bbs2-0014" title="YoussefH , CroftonVA , SmithSC , SiemensAJ . A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt. Contraception1987;35(2):101‐10. ">Youssef 1987</a> compared the Neo Sampoon vaginal tablet with Emko vaginal foam. The dose of nonoxynol‐9 contained in one applicator of the latter was not specified in the report; the only information provided is that the concentration was 8%. The trial was conducted in one clinic in Egypt. The duration of the study was 12 months, and a total of 349 women participated. </p> </section> </section> <section id="CD005218-sec2-0005"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="./references#CD005218-bbs2-0003" title="ChiI‐c , SmithSC , BorkoE , SunT‐H , BegumSF , HuntWL , et al. Clinical acceptability, use patterns and use‐effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets ‐ an international multi‐center randomized clinical trial. Contraception1987;36(36):499‐514. ">Chi 1987</a> featured high losses from the analysis by six months. Of 1299 participants enrolled at four sites, only 816 (63%) provided information at six months. The problem was most acute at the Bangladesh site, where only 39% returned at six months including just 12% of those randomized to the sponge. The study researchers did not present pregnancy rates for that site. Large losses of participants after randomization make the trial results suspect. </p> <p><a href="./references#CD005218-bbs2-0004" title="ChompootaweepS , DusitinN . A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol‐9 versus menfegol) in Thai women. Contraception1990;41(5):507‐17. ">Chompootaweep 1990</a> had acceptable randomization and blinding of participants and clinicians as to treatment. Four participants were inappropriately dropped from analysis after randomization for non‐compliance. Losses from analysis were high; only 47% of participants (48 of 102) provided information at the final scheduled visit at 12 months. These losses undermine the interpretation of the results. </p> <p><a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> also had an appropriate method of randomization, but there was no blinding of participants or researchers. The total losses of participants after randomization cannot be determined from the published report. Discontinuations were frequent; those who stopped use of the spermicide by 12 months included 33 of 99 assigned to Neo Sampoon, 47 of 101 assigned to the Ortho vaginal tablet, and 57 of 100 assigned to the Emko vaginal tablet. </p> <p><a href="./references#CD005218-bbs2-0010" title="RaymondE , DominikR , the spermicide trial group. Contraceptive effectiveness of two spermicides: a randomized trial. Obstetrics and Gynecology1999;93(6):896‐903. RaymondEG , AlvaradoG , LedesmaL , DiazS , BassolS , MoralesE , et al. Acceptability of two spermicides in five countries. Contraception1999;60(1):45‐50. ">Raymond 1999</a> featured excellent methods. A computer‐generated sequence was used to develop random‐permuted blocks of varying size. Allocation concealment was accomplished by sequentially‐numbered, sealed, opaque envelopes with method‐indicator cards. A formal sample size analysis was provided. Analysts were blinded as to treatment, although participants and investigators were not. When one planned interim analysis yielded higher failure rates than anticipated, all participants were advised and asked to sign a supplementary informed consent document. About 24% of participants discontinued the method early or were lost to follow up. </p> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> used similar rigorous methods. Computer‐generated random‐permuted blocks of randomly varied sizes were used for treatment assignment. Allocation concealment was assured by telephone calls to a central randomization center. A Data and Safety Monitoring Board oversaw the trial and performed one planned interim analysis, which did not influence the conduct of the trial. Blinding of participants and investigators was not done. The primary analysis included all participants who provided any follow‐up information until they no longer used the spermicide as their primary contraceptive method. In the intention‐to‐treat analysis, participants were kept in the analysis for the full seven months or until they were lost to follow up. After considering sample size and power issues and financial and time limitations, the investigators aimed for a total enrollment of 1800 women. Because recruitment proved difficult, enrollment was stopped at 1536. Fifty‐one women had no follow‐up information after admission, so the primary analysis included 1485 participants. Losses of participants after randomization were common. Approximately 39% of participants either discontinued the trial early or were deemed lost to follow up. No important disparities in these losses were seen among the five treatment groups, however. Overall, participants who dropped out had characteristics that suggested a higher risk of pregnancy than those who were retained. </p> <p>The trials conducted by Family Health International in the 1980s had common methods. These trials included published (<a href="./references#CD005218-bbs2-0014" title="YoussefH , CroftonVA , SmithSC , SiemensAJ . A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt. Contraception1987;35(2):101‐10. ">Youssef 1987</a>) and unpublished reports (<a href="./references#CD005218-bbs2-0001" title="Family Health International for Abdelsalaam A. A comparative study of Neo Sampoon tablets versus Emko tablets in Zagazig, Egypt. Unpublished report, Family Health International, May 1984. ">Abdelsalaam 1984</a>; <a href="./references#CD005218-bbs2-0002" title="Family Health International for Andolsek L. A comparative clinical trial of Neo Sampoon vaginal tablets and Emko vaginal foam in Ljubljana, Yugoslavia. Unpublished report, Family Health International, April 1988. ">Andolsek 1988</a>; <a href="./references#CD005218-bbs2-0005" title="Family Health International for Ghunney E. Evaluation of the safety, effectiveness and acceptability of Ortho foaming vaginal tablets containing nonoxynol‐9 versus Ortho foaming tablets containing menfegol at a clinic in Accra, Ghana. Unpublished report, Family Health International, December 1987. ">Ghunney 1987</a>; <a href="./references#CD005218-bbs2-0006" title="Family Health International for Kazi A. A comparative study of two foaming vaginal tablets for female barrier contraception in Pakistan. Unpublished report, Family Health International, September 1992. ">Kazi 1992</a>; <a href="./references#CD005218-bbs2-0007" title="Family Health International for Klufio C. Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming tablets containing menfegol at a hospital in Accra, Ghana. Unpublished report, Family Health International, February 1988. ">Klufio 1988</a>; <a href="./references#CD005218-bbs2-0009" title="Family Health International for Poindexter A III. A comparative study of Emko and Ortho vaginal tablets in Houston, Texas. Unpublished report, Family Health International, August 1984. ">Poindexter 1984</a>; <a href="./references#CD005218-bbs2-0012" title="Family Health International for Ruoff G, NilandN , HalkiJ . Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming vaginal tablets containing menfegol at three U.S. sites. Unpublished report, Family Health International, February 1988. ">Ruoff 1988</a>; <a href="./references#CD005218-bbs2-0013" title="Family Health International for Younis N. A comparative clinical trial of Emko and Ortho vaginal tablets in Cairo, Egypt. Unpublished report, Family Health International, October 1985. ">Younis 1985</a>). Randomization was done centrally by random‐permuted blocks with a computer‐generated sequence of numbers. Allocation concealment was achieved by using method‐indicator cards in sealed, opaque, sequentially‐numbered envelopes distributed to the research sites. Data were transmitted to Family Health International, where the analyses were done. Exclusion of participants because of protocol violations occurred in several reports, and losses to follow up ranged widely. In addition, recruitment problems were serious at some sites (<a href="./references#CD005218-bbs2-0005" title="Family Health International for Ghunney E. Evaluation of the safety, effectiveness and acceptability of Ortho foaming vaginal tablets containing nonoxynol‐9 versus Ortho foaming tablets containing menfegol at a clinic in Accra, Ghana. Unpublished report, Family Health International, December 1987. ">Ghunney 1987</a>; <a href="./references#CD005218-bbs2-0012" title="Family Health International for Ruoff G, NilandN , HalkiJ . Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming vaginal tablets containing menfegol at three U.S. sites. Unpublished report, Family Health International, February 1988. ">Ruoff 1988</a>), leading to premature closure of the trials. </p> </section> <section id="CD005218-sec2-0006"> <h3 class="title" id="CD005218-sec2-0006">Effects of interventions</h3> <p>Where available, the 12‐month life‐table rates per 100 women are presented for pregnancy and for discontinuation due to discomfort. Studies with shorter follow‐up periods reported the six‐month rates or probabilities. Some studies grouped discomfort with other personal reasons, so the outcome categories are described along with the results. A few trials reported the Pearl index, which represents the number of unintended pregnancies per 100 woman‐years of use. In these studies, the Pearl index was usually calculated with 12‐month data, but trials of shorter length used 6‐month data. The time frames are given with the specific results. </p> <p><a href="./references#CD005218-bbs2-0003" title="ChiI‐c , SmithSC , BorkoE , SunT‐H , BegumSF , HuntWL , et al. Clinical acceptability, use patterns and use‐effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets ‐ an international multi‐center randomized clinical trial. Contraception1987;36(36):499‐514. ">Chi 1987</a> compared the Collatex sponge (nonoxynol‐9 1.15 g) and Neo Sampoon tablet (menfegol 60 mg). Pregnancy rates varied widely by site, with rates five times higher in Taiwan than in Belgrade. Bangladesh was excluded from the pregnancy rates due to losses. Life‐table pregnancy rates at 12 months ranged from 3.8 to 18.2 per 100 women with the sponge and from 6.2 to 29.9 with the Neo Sampoon tablet. Results for the two methods were not significantly different. At all study sites, participants found the insertion of the sponge to be more difficult than insertion of the tablet. However, complaints of burning or stinging vaginal discharge were more common with the Neo Sampoon tablet than with the sponge; all four sites concurred. The study reported personal reasons for discontinuation, which included product‐related reasons, discomfort, and other reasons such as no confidence in the method. At six months, the discontinuation rates for these personal reasons were slightly higher for the sponge. At 12 months, two sites had slightly higher rates for the sponge than the tablet. These differences were not significant, however. </p> <p>Four trials performed a blinded comparison of vaginal foaming tablets with either nonoxynol‐9 100 mg or menfegol 60 mg as the active agent (<a href="./references#CD005218-bbs2-0004" title="ChompootaweepS , DusitinN . A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol‐9 versus menfegol) in Thai women. Contraception1990;41(5):507‐17. ">Chompootaweep 1990</a>; <a href="./references#CD005218-bbs2-0005" title="Family Health International for Ghunney E. Evaluation of the safety, effectiveness and acceptability of Ortho foaming vaginal tablets containing nonoxynol‐9 versus Ortho foaming tablets containing menfegol at a clinic in Accra, Ghana. Unpublished report, Family Health International, December 1987. ">Ghunney 1987</a>; <a href="./references#CD005218-bbs2-0007" title="Family Health International for Klufio C. Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming tablets containing menfegol at a hospital in Accra, Ghana. Unpublished report, Family Health International, February 1988. ">Klufio 1988</a>; <a href="./references#CD005218-bbs2-0012" title="Family Health International for Ruoff G, NilandN , HalkiJ . Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming vaginal tablets containing menfegol at three U.S. sites. Unpublished report, Family Health International, February 1988. ">Ruoff 1988</a>). Pregnancy rates among users of the two products were comparable over 6 and 12 months of use. Some trials had small numbers, e.g., 27 participants in a Ghana trial (<a href="./references#CD005218-bbs2-0005" title="Family Health International for Ghunney E. Evaluation of the safety, effectiveness and acceptability of Ortho foaming vaginal tablets containing nonoxynol‐9 versus Ortho foaming tablets containing menfegol at a clinic in Accra, Ghana. Unpublished report, Family Health International, December 1987. ">Ghunney 1987</a>), so pregnancy rates may be imprecise for single studies. Estimates for the Pearl index were also comparable for the two methods. Life‐table discontinuation rates for discomfort were available from the two larger trials in Thailand (<a href="./references#CD005218-bbs2-0004" title="ChompootaweepS , DusitinN . A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol‐9 versus menfegol) in Thai women. Contraception1990;41(5):507‐17. ">Chompootaweep 1990</a>) and Ghana (<a href="./references#CD005218-bbs2-0007" title="Family Health International for Klufio C. Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming tablets containing menfegol at a hospital in Accra, Ghana. Unpublished report, Family Health International, February 1988. ">Klufio 1988</a>). The rates ranged from 5.8 to 13.5 for nonoxynol‐9 and from 1.5 to 16.2 for menfegol, but they were not significantly different. In <a href="./references#CD005218-bbs2-0007" title="Family Health International for Klufio C. Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming tablets containing menfegol at a hospital in Accra, Ghana. Unpublished report, Family Health International, February 1988. ">Klufio 1988</a>, the 12‐month discontinuation rates for medical reasons were 9.0 for the menfegol and zero for the nonoxynol‐9. The difference was significant. </p> <p>Three trials compared the Neo Sampoon tablet with either the Ortho vaginal tablet (<a href="./references#CD005218-bbs2-0006" title="Family Health International for Kazi A. A comparative study of two foaming vaginal tablets for female barrier contraception in Pakistan. Unpublished report, Family Health International, September 1992. ">Kazi 1992</a>; <a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a>) or the Emko vaginal tablet (<a href="./references#CD005218-bbs2-0001" title="Family Health International for Abdelsalaam A. A comparative study of Neo Sampoon tablets versus Emko tablets in Zagazig, Egypt. Unpublished report, Family Health International, May 1984. ">Abdelsalaam 1984</a>; <a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a>). The Neo Sampoon tablet contained menfegol 60 mg and the Ortho and Emko tablets each had 100 mg of nonoxynol‐9. In Ghana (<a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a>), the 12‐month life‐table pregnancy rates were similar for the Neo Sampoon, Ortho vaginal, and Emko tablets. In Pakistan (<a href="./references#CD005218-bbs2-0006" title="Family Health International for Kazi A. A comparative study of two foaming vaginal tablets for female barrier contraception in Pakistan. Unpublished report, Family Health International, September 1992. ">Kazi 1992</a>), the 12‐month rates were 15.2 for menfegol and 22.5 for the Ortho tablet, but the study did not have the power to detect a significant difference. In Egypt (<a href="./references#CD005218-bbs2-0001" title="Family Health International for Abdelsalaam A. A comparative study of Neo Sampoon tablets versus Emko tablets in Zagazig, Egypt. Unpublished report, Family Health International, May 1984. ">Abdelsalaam 1984</a>), the six‐month pregnancy rates were also similar for menfegol and the Emko nonoxynol‐9. Only <a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> provided the Pearl index, and the figures were 10.6 for menfegol, 13.8 for Ortho nonoxynol‐9, and 17.9 for Emko nonoxynol‐9. </p> <p>The discontinuation rates for discomfort or medical reasons varied across these three studies. In <a href="./references#CD005218-bbs2-0001" title="Family Health International for Abdelsalaam A. A comparative study of Neo Sampoon tablets versus Emko tablets in Zagazig, Egypt. Unpublished report, Family Health International, May 1984. ">Abdelsalaam 1984</a>, the six‐month discontinuation rates for discomfort were similar for menfegol and the Emko tablet. Discontinuation rates were also similar for medical and product‐related reasons. In <a href="./references#CD005218-bbs2-0006" title="Family Health International for Kazi A. A comparative study of two foaming vaginal tablets for female barrier contraception in Pakistan. Unpublished report, Family Health International, September 1992. ">Kazi 1992</a>, the 12‐month discontinuation rates for medical reasons (including discomfort) were similar for the two groups but somewhat higher overall. <a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> noted significant differences in the 12‐month discontinuation rates for discomfort. The rates were zero for menfegol, 2.7 for the Ortho nonoxynol‐9, and 12.8 for the Emko tablet. </p> <p>Three trials compared the Ortho vaginal tablet with the Emko vaginal tablet, each of which contained nonoxynol‐9 100 mg (<a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a>; <a href="./references#CD005218-bbs2-0009" title="Family Health International for Poindexter A III. A comparative study of Emko and Ortho vaginal tablets in Houston, Texas. Unpublished report, Family Health International, August 1984. ">Poindexter 1984</a>; <a href="./references#CD005218-bbs2-0013" title="Family Health International for Younis N. A comparative clinical trial of Emko and Ortho vaginal tablets in Cairo, Egypt. Unpublished report, Family Health International, October 1985. ">Younis 1985</a>). The 12‐month life‐table pregnancy rates were nearly identical in <a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> and <a href="./references#CD005218-bbs2-0013" title="Family Health International for Younis N. A comparative clinical trial of Emko and Ortho vaginal tablets in Cairo, Egypt. Unpublished report, Family Health International, October 1985. ">Younis 1985</a>. The Pearl index results from <a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> were given earlier. Discontinuations because of discomfort by 12 months were divergent, however. In Ghana (<a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a>), Emko tablets had a discontinuation rate of 12.8 versus 2.7 for the Ortho tablet, and the difference was significant. In Egypt (<a href="./references#CD005218-bbs2-0013" title="Family Health International for Younis N. A comparative clinical trial of Emko and Ortho vaginal tablets in Cairo, Egypt. Unpublished report, Family Health International, October 1985. ">Younis 1985</a>), the rate was nearly twice as high for the Ortho tablet (11.6) as for the Emko (5.6), but the difference was not significant. The third trial (<a href="./references#CD005218-bbs2-0009" title="Family Health International for Poindexter A III. A comparative study of Emko and Ortho vaginal tablets in Houston, Texas. Unpublished report, Family Health International, August 1984. ">Poindexter 1984</a>) compared the same two tablets, although the observation period was 6 months rather than 12. In this small U.S. study, discontinuation rates for pregnancy or discomfort were similar. </p> <p>Two trials (<a href="./references#CD005218-bbs2-0014" title="YoussefH , CroftonVA , SmithSC , SiemensAJ . A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt. Contraception1987;35(2):101‐10. ">Youssef 1987</a>; <a href="./references#CD005218-bbs2-0002" title="Family Health International for Andolsek L. A comparative clinical trial of Neo Sampoon vaginal tablets and Emko vaginal foam in Ljubljana, Yugoslavia. Unpublished report, Family Health International, April 1988. ">Andolsek 1988</a>) compared the Neo Sampoon tablet (menfegol 60 mg) with Emko foam (nonoxynol‐9 8%) over 12 months of use. Life‐table pregnancy rates were similar for the two methods in both trials. Discontinuation rates due to discomfort were also similar. Overall, rates were higher in <a href="./references#CD005218-bbs2-0002" title="Family Health International for Andolsek L. A comparative clinical trial of Neo Sampoon vaginal tablets and Emko vaginal foam in Ljubljana, Yugoslavia. Unpublished report, Family Health International, April 1988. ">Andolsek 1988</a> than in <a href="./references#CD005218-bbs2-0014" title="YoussefH , CroftonVA , SmithSC , SiemensAJ . A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt. Contraception1987;35(2):101‐10. ">Youssef 1987</a>. </p> <p><a href="./references#CD005218-bbs2-0010" title="RaymondE , DominikR , the spermicide trial group. Contraceptive effectiveness of two spermicides: a randomized trial. Obstetrics and Gynecology1999;93(6):896‐903. RaymondEG , AlvaradoG , LedesmaL , DiazS , BassolS , MoralesE , et al. Acceptability of two spermicides in five countries. Contraception1999;60(1):45‐50. ">Raymond 1999</a> found similar results with the vaginal contraceptive film and vaginal tablet, which contained nonoxynol‐9 72 mg and 100 mg, respectively. Conducted at eight international sites, the trial found the six‐month probabilities of pregnancy to be 28% for the tablet and 25% for the film. The Pearl index was calculated with the six‐month data, and the figures were 67.4 for the tablet and 59.8 for the film. Acceptability was addressed in a separate report; it revealed mixed results. Slightly more women assigned to the film liked their method "very much" (55%) as compared with those randomized to the tablet (50%). On the other hand, somewhat fewer participants assigned to the film reported having had no problems with the method (30%) compared with those assigned to the tablet (37%). The differences were not significant. Acceptability varied considerably by study site. In general, the film was more likely to stick to fingers and the tablet was easier to insert, although more women considered the tablet messy. </p> <p>In <a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>, the gel containing the lowest dose of nonoxynol‐9 (52.5 mg) was significantly less effective in preventing pregnancy than were the higher doses (100 mg and 150 mg). Probabilities of pregnancy by six months were 22% for the 52.5 mg gel, 16% for the 100 mg dose, and 14% for the 150 mg dose. The three different formulations (gel, film, and vaginal suppository) with 100 mg of nonoxynol‐9 had similar efficacy. The probabilities of pregnancy were 12% with the 100 mg film and 10% with the 100 mg suppository. </p> <p>All the spermicide products were safe (<a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>). Thirty‐four serious adverse events occurred during the trial, none of which was judged related to the spermicide. The seven‐month probability did not differ among the groups for vaginal candidiasis, bacterial vaginosis, irritation without infection, and urinary tract infection. </p> <p>Gel was more acceptable to women than the Encare suppository (<a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>). Significantly more women who used the 100 mg gel liked it "very much" compared to those who used the 100 mg film or the 100 mg suppository. The percentages were 49% for the gel, 41% for the film, and 34% for the suppository. </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005218-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005218-sec1-0005"></div> <p>A striking range of contraceptive efficacy with vaginal spermicides has been reported to date. Percentages for unintended pregnancy in the first year of use are 18% for perfect use and 28% for typical use (<a href="./references#CD005218-bbs2-0031" title="TrussellJ . Contraceptive failure in the United States. Contraception2011;83(5):397‐404. ">Trussell 2011</a>). In the international trial of <a href="./references#CD005218-bbs2-0010" title="RaymondE , DominikR , the spermicide trial group. Contraceptive effectiveness of two spermicides: a randomized trial. Obstetrics and Gynecology1999;93(6):896‐903. RaymondEG , AlvaradoG , LedesmaL , DiazS , BassolS , MoralesE , et al. Acceptability of two spermicides in five countries. Contraception1999;60(1):45‐50. ">Raymond 1999</a>, approximately a fifth of all participants became pregnant within six months with either the VCF film or the Conceptrol tablet. In contrast, in Egypt, the 12‐month life‐table rates of pregnancy were 2.8 for users of the Neo Sampoon tablet and 2.1 for Emko foam users (<a href="./references#CD005218-bbs2-0014" title="YoussefH , CroftonVA , SmithSC , SiemensAJ . A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt. Contraception1987;35(2):101‐10. ">Youssef 1987</a>). These wide variations presumably reflect important differences in fecundability as well as compliance and continuation with the assigned product. In addition, some studies reported more meticulous methods than others for follow up, which can affect the ascertainment of pregnancy data. However, poor trial quality was a generic problem. </p> <p>The efficacy of spermicides may be dose‐related. The gel containing only 52.5 mg of nonoxynol‐9 was associated with a higher pregnancy risk than were gels containing higher doses of the same agent in <a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>. </p> <p>Several differences emerged in discontinuation rates due to discomfort or medical problems. For example, women using the Collatex sponge were slightly more likely to discontinue because of problems and personal reasons than were those using the Neo Sampoon tablet (<a href="./references#CD005218-bbs2-0003" title="ChiI‐c , SmithSC , BorkoE , SunT‐H , BegumSF , HuntWL , et al. Clinical acceptability, use patterns and use‐effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets ‐ an international multi‐center randomized clinical trial. Contraception1987;36(36):499‐514. ">Chi 1987</a>). In another trial, those using the Neo Sampoon tablet were less likely to discontinue due to discomfort than were women using Emko tablets (<a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a>). </p> <p>In the five‐arm trial of <a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>, clear differences emerged in the acceptability of different vehicles. A gel was more acceptable than the vaginal suppository. A higher proportion of women liked the gel "very much" compared with the Encare suppository and the Ortho Contraceptive film. </p> <p>Losses of participants after randomization threaten trial validity (<a href="./references#CD005218-bbs2-0026" title="SchulzKF , GrimesDA . Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet2002;359(9308):781‐5. ">Schulz 2002</a>). These trials were all hampered by retention problems. In some studies, many participants discontinued their method prematurely, and the investigators made no further attempts to track these women. Other participants were lost to follow‐up despite efforts to locate them and determine outcomes. <a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> examined characteristics of those who withdrew before the planned end of the observation period in the large U.S. trial of five products (<a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a>). About 40% of women did not complete the study for reasons other than pregnancy. Those more likely to discontinue early were younger, unmarried women with intercourse at least eight times per month and were enrolled at a university site or a site that had slow enrollment. However, many participants without these features also quit early. Hence, targeting retention efforts in future trials will be difficult. A '5‐and‐20' rule of thumb suggests that losses after randomization of 5% or less are unlikely to influence trial validity. In contrast, losses of 20% or more make results suspect (<a href="./references#CD005218-bbs2-0030" title="StraussSE , RichardsonWS , GlasziouP , HaynesRB . Evidence‐based Medicine: How to Practice and Teach EBM. Third Edition. New York: Churchill Livingstone, 2005. ">Strauss 2005</a>). </p> </section> </section> <div class="figures-list"> <div class="figure" id="CD005218-fig-00101"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Site</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 sponge</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol tablet</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Belgrade</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maribor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.9</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Collatex vaginal sponge (nonoxynol‐9 1.15 g) versus Neo Sampoon tablet (menfegol 60 mg), Outcome 1 Life‐table rates per 100 women for pregnancy (12‐month). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00101">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00102"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Site</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 sponge</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol tablet</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Begrade</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maribor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bangladesh</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.2</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Collatex vaginal sponge (nonoxynol‐9 1.15 g) versus Neo Sampoon tablet (menfegol 60 mg), Outcome 2 Life‐table rates per 100 women for discontinuation due to personal reasons (6‐month). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00102">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00103"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Site</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 sponge</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol tablet</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Belgrade</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maribor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chi 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bangladesh</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.3</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Collatex vaginal sponge (nonoxynol‐9 1.15 g) versus Neo Sampoon tablet (menfegol 60 mg), Outcome 3 Life‐table rates per 100 women for discontinuation due to personal reasons (12‐month). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00103">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00201"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 tablet</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol tablet</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chompootaweep 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ghunney 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Klufio 1988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ruoff 1988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.7</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Ortho vaginal tablets: nonoxynol‐9 100 mg versus menfegol 60 mg, Outcome 1 Life‐table rates per 100 women for pregnancy (6‐month). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00201">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00202"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 tablet</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol tablet</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chompootaweep 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Klufio 1988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.8</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Ortho vaginal tablets: nonoxynol‐9 100 mg versus menfegol 60 mg, Outcome 2 Life‐table rates per 100 women for pregnancy (12‐month). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00202">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00203"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time frame</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 tablet</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol tablet</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chompootaweep 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ghunney 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Klufio 1988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ruoff 1988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45.1</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Ortho vaginal tablets: nonoxynol‐9 100 mg versus menfegol 60 mg, Outcome 3 Pearl index per 100 woman‐years. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00203">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00204"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time frame</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 tablet</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol tablet</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chompootaweep 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chompootaweep 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Klufio 1988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Klufio 1988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Ortho vaginal tablets: nonoxynol‐9 100 mg versus menfegol 60 mg, Outcome 4 Life‐table rates per 100 women for discontinuation due to discomfort. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00204">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00301"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time frame</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand of nonoxynol‐9</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 100 mg</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol 60 mg</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Abdelsalaam 1984</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emko</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kazi 1992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamptey 1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐month<br/> 12‐month </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho<br/> Emko </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.3<br/> 12.5 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.6<br/> 9.6 </p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Ortho or Emko tablet (nonoxynol‐9 100 mg) versus Neo Sampoon tablet (menfegol 60 mg), Outcome 1 Life‐table rates per 100 women for pregnancy. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00301">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00302"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time frame</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 brand</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 100 mg</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol 60 mg</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Assessment</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Abdelsalaam 1984</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emko</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>discomfort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kazi 1992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>medical reasons including discomfort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamptey 1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Vaginal<br/> Emko </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7<br/> 12.8 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0<br/> 0 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>discomfort</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Ortho or Emko tablet (nonoxynol‐9 100 mg) versus Neo Sampoon tablet (menfegol 60 mg), Outcome 2 Life‐table rates per 100 women for discontinuation due to discomfort and/or medical reasons. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00302">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00401"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time frame</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 Ortho</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 Emko</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamptey 1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poindexter 1984</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Younis 1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.7</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Ortho tablet (nonoxynol‐9 100 mg) versus Emko tablet (nonoxynol‐9 100 mg), Outcome 1 Life‐table rates per 100 women for pregnancy. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00401">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00402"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time frame</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 Ortho</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 Emko</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamptey 1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poindexter 1984</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Younis 1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Ortho tablet (nonoxynol‐9 100 mg) versus Emko tablet (nonoxynol‐9 100 mg), Outcome 2 Life‐table rates per 100 women for discontinuation due to discomfort. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00402">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00501"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 8% foam</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol tablet</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Andolsek 1988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Youssef 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.8</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Emko foam (nonoxynol‐9 8% concentration) versus Neo Sampoon tablet (menfegol 60 mg), Outcome 1 Life‐table rates per 100 women for pregnancy (12‐month). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00501">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00502"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nonoxynol‐9 8% foam</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menfegol tablet</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Andolsek 1988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Youssef 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.6</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Emko foam (nonoxynol‐9 8% concentration) versus Neo Sampoon tablet (menfegol 60 mg), Outcome 2 Life‐table rates per 100 women for discontinuation due to discomfort (12‐month). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00502">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00601"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Tablet 100 mg</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>VCF film 72 mg</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.9</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Ortho tablet (nonoxynol‐9 100 mg) versus VCF film (nonoxynol‐9 72 mg), Outcome 1 Probability of pregnancy through six months of typical use. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00601">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00701"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand name</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pregnancy probability</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advantage S gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.2%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.5%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol film</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.9%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Encare suppository</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0%</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Nonoxynol‐9 gels (52.5 mg, 100 mg, 150 mg); Nonoxynol‐9 film 100 mg; Nonoxynol‐9 suppository 100 mg, Outcome 1 Probability of pregnancy through six months of typical use. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00701">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00702"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand name</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Discontinued</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advantage S gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol film</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Encare suppository</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17%</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Nonoxynol‐9 gels (52.5 mg, 100 mg, 150 mg); Nonoxynol‐9 film 100 mg; Nonoxynol‐9 suppository 100 mg, Outcome 2 Discontinued method early. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00702">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005218-fig-00703"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand name</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Liked "very much"</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advantage S gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol film</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Raymond 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Encare suppository</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34%</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Nonoxynol‐9 gels (52.5 mg, 100 mg, 150 mg); Nonoxynol‐9 film 100 mg; Nonoxynol‐9 suppository 100 mg, Outcome 3 Liked the method "very much". </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-fig-00703">Navigate to figure in review</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD005218-tbl-0008"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of spermicides tested</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand name</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Spermicide and dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neo Sampoon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Menfegol 60 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0001" title="Family Health International for Abdelsalaam A. A comparative study of Neo Sampoon tablets versus Emko tablets in Zagazig, Egypt. Unpublished report, Family Health International, May 1984. ">Abdelsalaam 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0002" title="Family Health International for Andolsek L. A comparative clinical trial of Neo Sampoon vaginal tablets and Emko vaginal foam in Ljubljana, Yugoslavia. Unpublished report, Family Health International, April 1988. ">Andolsek 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0003" title="ChiI‐c , SmithSC , BorkoE , SunT‐H , BegumSF , HuntWL , et al. Clinical acceptability, use patterns and use‐effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets ‐ an international multi‐center randomized clinical trial. Contraception1987;36(36):499‐514. ">Chi 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0006" title="Family Health International for Kazi A. A comparative study of two foaming vaginal tablets for female barrier contraception in Pakistan. Unpublished report, Family Health International, September 1992. ">Kazi 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0014" title="YoussefH , CroftonVA , SmithSC , SiemensAJ . A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt. Contraception1987;35(2):101‐10. ">Youssef 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho menfegol foaming tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Menfegol 60 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0004" title="ChompootaweepS , DusitinN . A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol‐9 versus menfegol) in Thai women. Contraception1990;41(5):507‐17. ">Chompootaweep 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0005" title="Family Health International for Ghunney E. Evaluation of the safety, effectiveness and acceptability of Ortho foaming vaginal tablets containing nonoxynol‐9 versus Ortho foaming tablets containing menfegol at a clinic in Accra, Ghana. Unpublished report, Family Health International, December 1987. ">Ghunney 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0007" title="Family Health International for Klufio C. Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming tablets containing menfegol at a hospital in Accra, Ghana. Unpublished report, Family Health International, February 1988. ">Klufio 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0012" title="Family Health International for Ruoff G, NilandN , HalkiJ . Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming vaginal tablets containing menfegol at three U.S. sites. Unpublished report, Family Health International, February 1988. ">Ruoff 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Collatex sponge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 1.15 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0003" title="ChiI‐c , SmithSC , BorkoE , SunT‐H , BegumSF , HuntWL , et al. Clinical acceptability, use patterns and use‐effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets ‐ an international multi‐center randomized clinical trial. Contraception1987;36(36):499‐514. ">Chi 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emko tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0001" title="Family Health International for Abdelsalaam A. A comparative study of Neo Sampoon tablets versus Emko tablets in Zagazig, Egypt. Unpublished report, Family Health International, May 1984. ">Abdelsalaam 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0002" title="Family Health International for Andolsek L. A comparative clinical trial of Neo Sampoon vaginal tablets and Emko vaginal foam in Ljubljana, Yugoslavia. Unpublished report, Family Health International, April 1988. ">Andolsek 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0009" title="Family Health International for Poindexter A III. A comparative study of Emko and Ortho vaginal tablets in Houston, Texas. Unpublished report, Family Health International, August 1984. ">Poindexter 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0013" title="Family Health International for Younis N. A comparative clinical trial of Emko and Ortho vaginal tablets in Cairo, Egypt. Unpublished report, Family Health International, October 1985. ">Younis 1985</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emko foam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0002" title="Family Health International for Andolsek L. A comparative clinical trial of Neo Sampoon vaginal tablets and Emko vaginal foam in Ljubljana, Yugoslavia. Unpublished report, Family Health International, April 1988. ">Andolsek 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0014" title="YoussefH , CroftonVA , SmithSC , SiemensAJ . A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt. Contraception1987;35(2):101‐10. ">Youssef 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho foaming tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0004" title="ChompootaweepS , DusitinN . A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol‐9 versus menfegol) in Thai women. Contraception1990;41(5):507‐17. ">Chompootaweep 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0005" title="Family Health International for Ghunney E. Evaluation of the safety, effectiveness and acceptability of Ortho foaming vaginal tablets containing nonoxynol‐9 versus Ortho foaming tablets containing menfegol at a clinic in Accra, Ghana. Unpublished report, Family Health International, December 1987. ">Ghunney 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0007" title="Family Health International for Klufio C. Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming tablets containing menfegol at a hospital in Accra, Ghana. Unpublished report, Family Health International, February 1988. ">Klufio 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0012" title="Family Health International for Ruoff G, NilandN , HalkiJ . Evaluation of the safety, effectiveness and acceptability of Ortho contraceptive foaming vaginal tablets containing nonoxynol‐9 versus Ortho contraceptive foaming vaginal tablets containing menfegol at three U.S. sites. Unpublished report, Family Health International, February 1988. ">Ruoff 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0006" title="Family Health International for Kazi A. A comparative study of two foaming vaginal tablets for female barrier contraception in Pakistan. Unpublished report, Family Health International, September 1992. ">Kazi 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0008" title="LampteyP , KlufioC , SmithSC , FeldblumPJ . A comparative study of Neo Sampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception1985;32(5):445‐54. ">Lamptey 1985</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0009" title="Family Health International for Poindexter A III. A comparative study of Emko and Ortho vaginal tablets in Houston, Texas. Unpublished report, Family Health International, August 1984. ">Poindexter 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0013" title="Family Health International for Younis N. A comparative clinical trial of Emko and Ortho vaginal tablets in Cairo, Egypt. Unpublished report, Family Health International, October 1985. ">Younis 1985</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0010" title="RaymondE , DominikR , the spermicide trial group. Contraceptive effectiveness of two spermicides: a randomized trial. Obstetrics and Gynecology1999;93(6):896‐903. RaymondEG , AlvaradoG , LedesmaL , DiazS , BassolS , MoralesE , et al. Acceptability of two spermicides in five countries. Contraception1999;60(1):45‐50. ">Raymond 1999</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VCF film</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 72 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0010" title="RaymondE , DominikR , the spermicide trial group. Contraceptive effectiveness of two spermicides: a randomized trial. Obstetrics and Gynecology1999;93(6):896‐903. RaymondEG , AlvaradoG , LedesmaL , DiazS , BassolS , MoralesE , et al. Acceptability of two spermicides in five countries. Contraception1999;60(1):45‐50. ">Raymond 1999</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advantage S gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 52.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 150 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ortho Conceptrol film</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Encare suppository</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nonoxynol‐9 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005218-bbs2-0011" title="RaymondE , ChenPL , Pierre LouisB , LuotoJ , BarnhartK , BradleyL , et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology2004;4(1):23. [DOI: 10.1186/1471/‐2288‐4‐23] RaymondEG , ChenPL , CondonS , LuotoJ , BarnhartKT , BradleyL , et al. Acceptability of five nonoxynol‐9 spermicides. Contraception2005;71(6):438‐42. RaymondEG , ChenPL , LuotoJ , for the spermicide trial group. Contraceptive effectiveness and safety of five nonoxynol‐9 spermicides: a randomized trial. Obstetrics and Gynecology2004;103(3):430‐9. ">Raymond 2004</a> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of spermicides tested</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/full#CD005218-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005218-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Collatex vaginal sponge (nonoxynol‐9 1.15 g) versus Neo Sampoon tablet (menfegol 60 mg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Life‐table rates per 100 women for pregnancy (12‐month) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Life‐table rates per 100 women for discontinuation due to personal reasons (6‐month) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Life‐table rates per 100 women for discontinuation due to personal reasons (12‐month) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Collatex vaginal sponge (nonoxynol‐9 1.15 g) versus Neo Sampoon tablet (menfegol 60 mg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005218-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Ortho vaginal tablets: nonoxynol‐9 100 mg versus menfegol 60 mg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Life‐table rates per 100 women for pregnancy (6‐month) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Life‐table rates per 100 women for pregnancy (12‐month) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pearl index per 100 woman‐years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Life‐table rates per 100 women for discontinuation due to discomfort <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Ortho vaginal tablets: nonoxynol‐9 100 mg versus menfegol 60 mg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005218-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Ortho or Emko tablet (nonoxynol‐9 100 mg) versus Neo Sampoon tablet (menfegol 60 mg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Life‐table rates per 100 women for pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Life‐table rates per 100 women for discontinuation due to discomfort and/or medical reasons <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Ortho or Emko tablet (nonoxynol‐9 100 mg) versus Neo Sampoon tablet (menfegol 60 mg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005218-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Ortho tablet (nonoxynol‐9 100 mg) versus Emko tablet (nonoxynol‐9 100 mg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Life‐table rates per 100 women for pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Life‐table rates per 100 women for discontinuation due to discomfort <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Ortho tablet (nonoxynol‐9 100 mg) versus Emko tablet (nonoxynol‐9 100 mg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005218-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Emko foam (nonoxynol‐9 8% concentration) versus Neo Sampoon tablet (menfegol 60 mg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Life‐table rates per 100 women for pregnancy (12‐month) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Life‐table rates per 100 women for discontinuation due to discomfort (12‐month) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Emko foam (nonoxynol‐9 8% concentration) versus Neo Sampoon tablet (menfegol 60 mg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005218-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Ortho tablet (nonoxynol‐9 100 mg) versus VCF film (nonoxynol‐9 72 mg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Probability of pregnancy through six months of typical use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Ortho tablet (nonoxynol‐9 100 mg) versus VCF film (nonoxynol‐9 72 mg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005218-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Nonoxynol‐9 gels (52.5 mg, 100 mg, 150 mg); Nonoxynol‐9 film 100 mg; Nonoxynol‐9 suppository 100 mg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Probability of pregnancy through six months of typical use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Discontinued method early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Liked the method "very much" <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Nonoxynol‐9 gels (52.5 mg, 100 mg, 150 mg); Nonoxynol‐9 film 100 mg; Nonoxynol‐9 suppository 100 mg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005218.pub4/references#CD005218-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005218.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"/> </noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005218-note-1205">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD005218-note-1204">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"/> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"/> </a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005218\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005218\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005218\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005218\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005218\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005218.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005218.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005218.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005218.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005218.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727315205"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005218.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727315209"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005218.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea9119a639377',t:'MTc0MDcyNzMxNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 